يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"Benoit Tessoulin"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

    المؤلفون: Maud D'Aveni-Piney, Catherine Thieblemont, Caroline Bodet-Milin, Loic Ysebaert, Pierre Feugier, Eugenio Galli, Marie-Thérèse Rubio, Roberta Di Blasi, Pierre Bories, Benoit Tessoulin, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Sylvie Chevret, Sophie Bernard, Laetitia Vercellino, Céline Bossard, Salim Kanoun, Lucie Oberic, Pascal Merlet, Michel Meignan, Olivier Casasnovas, Steven Le Gouill, Véronique Meignin, Cédric Rossi

    المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Médecine Nucléaire [Toulouse], CHU Toulouse [Toulouse], Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Lipides - Nutrition - Cancer [Dijon - U1231] (LNC), Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Service d'Hématologie [IUCT Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Médecine Nucléaire [Nantes], Hôpital Laennec, Service de Médecine Nucléaire [Nancy], Service de Médecine Nucléaire, Centre Georges-François Leclerc [Dijon] (CGFL), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER, Centre hospitalier universitaire de Nantes (CHU Nantes), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), CHU Henri Mondor, Service de biostatistiques et information médicale [Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université de Paris (UP), NF-kappaB, Différenciation et Cancer (OncokappaB (URP_7324)), Université de Paris (UP)

    المصدر: Blood Advances
    Blood Advances, The American Society of Hematology, 2020, 4 (22), pp.5607-5615. ⟨10.1182/bloodadvances.2020003001⟩

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Immunotherapy, Adoptive, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, Refractory, Internal medicine, medicine, Humans, Progression-free survival, Stage (cooking), Retrospective Studies, Univariate analysis, business.industry, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, medicine.disease, Progression-Free Survival, Confidence interval, Tumor Burden, 3. Good health, Lymphoma, 030104 developmental biology, 030220 oncology & carcinogenesis, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b79f675b2891c55ed31da5653be9089Test
    https://doi.org/10.1182/bloodadvances.2020003001Test


    أضف إلى المفضلة
  2. 2
    Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide

    المؤلفون: Steven Le Gouill, Ana Berceanu, A. Dormoy, Patrice Chevallier, Yohan Desbrosses, Caroline Malugani, Céline Bressollette, Berthe-Marie Imbert, Benoit Tessoulin, Thomas Gastinne, Eric Deconinck, Beatrice Mahe, Nicolas Blin, Philippe Moreau, Thierry Guillaume, Marie C. Béné, Marion Eveillard, Sophie Vantyghem, Amandine Le Bourgeois, Alix Duquesne, Etienne Daguindau, Yannick Le Bris, Alice Garnier, Cyrille Touzeau, Viviane Dubruille, Anne Lok, Pierre Peterlin

    المصدر: Acta Oncologica. 60:466-474

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Post transplant cyclophosphamide, Graft vs Host Disease, Peripheral Blood Stem Cells, Gastroenterology, 030218 nuclear medicine & medical imaging, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Immune system, immune system diseases, Internal medicine, Acute graft versus host disease, medicine, Humans, Clofarabine, Radiology, Nuclear Medicine and imaging, In patient, Cyclophosphamide, Aged, Retrospective Studies, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, General Medicine, Middle Aged, Prognosis, Peripheral blood, surgical procedures, operative, Oncology, 030220 oncology & carcinogenesis, Female, Good prognosis, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44473c26b006301b7d5e4d414f07c1c1Test
    https://doi.org/10.1080/0284186x.2020.1837947Test


    أضف إلى المفضلة
  3. 3
    Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide

    المؤلفون: Beatrice Mahe, Nicolas Blin, Alix Duquesne, Alice Garnier, Anne Lok, Pierre Peterlin, Marie C. Béné, Marion Eveillard, Amandine Le Bourgeois, Thomas Gastinne, Thierry Guillaume, Viviane Dubruille, Cyrille Touzeau, Philippe Moreau, Steven Le Gouill, Patrice Chevallier, Benoit Tessoulin

    المصدر: Annals of Hematology. 99:1341-1350

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, CD3 Complex, Cyclophosphamide, Antigens, CD34, Context (language use), Gastroenterology, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Clofarabine, Aged, Retrospective Studies, Hematology, business.industry, Incidence (epidemiology), Graft Survival, Hematopoietic Stem Cell Transplantation, General Medicine, Middle Aged, Fludarabine, Transplantation, Treatment Outcome, 030220 oncology & carcinogenesis, Cohort, Female, business, Immunosuppressive Agents, Follow-Up Studies, 030215 immunology, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f819735a2fa9fe5e3fac72ce75957cTest
    https://doi.org/10.1007/s00277-020-04031-4Test


    أضف إلى المفضلة
  4. 4
    Long‐term efficacy and safety of 2CdA (cladribine) in extra‐pulmonary adult‐onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review

    المؤلفون: Claire Dromer, Antoine Néel, Hélène Maillard, Denis Jullien, Anne-Maelle Fontenoy, Carla Araujo, Gwenaël Lorillon, Fleur Cohen-Aubart, Mohamed Hamidou, Loïc Guillevin, Mathilde de Menthon, Benoit Tessoulin, Abdellatif Tazi, Mathieu Artifoni, Jean Donadieu, Julien Haroche, Jean-Emmanuel Kahn, Olivier Hermine, Thierry Généreau

    المصدر: British Journal of Haematology. 189:869-878

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neutropenia, Antimetabolites, medicine.medical_treatment, Kaplan-Meier Estimate, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Langerhans cell histiocytosis, Sepsis, Internal medicine, medicine, Humans, Age of Onset, Cladribine, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Chemotherapy, Dose-Response Relationship, Drug, Cumulative dose, business.industry, Remission Induction, Hematology, Middle Aged, medicine.disease, Vinblastine, Histiocytosis, Langerhans-Cell, Histiocytosis, Virus Diseases, 030220 oncology & carcinogenesis, Cytarabine, Female, France, business, Immunosuppressive Agents, 030215 immunology, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1537d8c8eea94e1c0426535df1e0c0Test
    https://doi.org/10.1111/bjh.16449Test


    أضف إلى المفضلة
  5. 5
    Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

    المؤلفون: Thomas Gastinne, Sylviane Ragot, Krimo Bouabdallah, David Chiron, Rory McCulloch, Céline Bossard, Cédric Rossi, Caroline Bodet-Milin, Emmanuelle Tchernonog, Simon Rule, Benoit Tessoulin, Guillaume Cartron, Nathalie Nadal, Steven Le Gouill, Olivier Casasnovas, Franck Morschhauser, Mary B. Callanan, Charles Herbaux

    المصدر: Blood. 137(7)

    مصطلحات موضوعية: 0301 basic medicine, Male, Neoplasm, Residual, medicine.medical_treatment, Immunoglobulin Variable Region, Hematopoietic stem cell transplantation, Kaplan-Meier Estimate, Lymphoma, Mantle-Cell, Biochemistry, Gastroenterology, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Obinutuzumab, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Prospective cohort study, Aged, 80 and over, Sulfonamides, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Combined Modality Therapy, Progression-Free Survival, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Ibrutinib, Female, Immunoglobulin Heavy Chains, medicine.medical_specialty, Maximum Tolerated Dose, Immunology, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, Humans, Progression-free survival, Aged, Venetoclax, business.industry, Adenine, Cell Biology, medicine.disease, Bridged Bicyclo Compounds, Heterocyclic, Genes, p53, Minimal residual disease, Hematologic Diseases, 030104 developmental biology, chemistry, Mutation, Mantle cell lymphoma, business, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef98b66a8d9d75e55b3807ede12c5cd7Test
    https://pubmed.ncbi.nlm.nih.gov/33599764Test


    أضف إلى المفضلة
  6. 6
    Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

    المؤلفون: Franck Morschhauser, Clément Bailly, Corinne Haioun, Benoit Tessoulin, Hervé Tilly, Vincent Ribrag, Marc André, Steven Le Gouill, Catherine Thieblemont, Bruno Villemagne, Thierry Lamy, Lucie Oberic, René-Olivier Casasnovas, Luc-Matthieu Fornecker, Kamal Bouabdallah, Remy Gressin, Maxime Jullien, Pierre Feugier, Guillaume Cartron, Jean-Marc Schiano de Colella, Olivier Hermine, Hervé Ghesquières, Gandhi Damaj, Christophe Bonnet

    المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'hématologie, Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre hospitalier universitaire de Nantes (CHU Nantes), Hospices Civils de Lyon (HCL), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Lille, Recherche translationelle relations hôte-pathogènes, Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Institut Gustave Roussy (IGR), Université Paris-Saclay, Département d'hématologie [Gustave Roussy], CHU Pontchaillou [Rennes], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Bordeaux [Bordeaux], Hôpital Henri Mondor, Institut d'Hématologie de Basse-Normandie (IHBN), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER, Institut de Cancérologie de Strasbourg Europe (ICANS), CHU Strasbourg, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Necker - Enfants Malades [AP-HP], CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Liège (CHU-Liège), Université de Liège, CHU UCL Namur, Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Lipides - Nutrition - Cancer [Dijon - U1231] (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Bernardo, Elizabeth

    المصدر: Cancers, Vol. 13, no. 18, p. 4503 [1-12] (2021)
    Cancers
    Cancers, 2021, 13 (18), pp.4503. ⟨10.3390/cancers13184503⟩
    Cancers, Vol 13, Iss 4503, p 4503 (2021)
    Volume 13
    Issue 18

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, diffuse large B-cell lymphoma, convolutional neural network, [SDV.CAN]Life Sciences [q-bio]/Cancer, muscle depletion, Gastroenterology, Article, sarcopenia, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Hounsfield scale, medicine, Progression-free survival, Risk factor, RC254-282, Predictive marker, muscle hypodensity, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Skeletal muscle, medicine.disease, U-NET, medicine.anatomical_structure, Oncology, Sarcopenia, Cohort, business, Diffuse large B-cell lymphoma

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::812249376c936295239e431d86bea1f7Test
    https://doi.org/10.3390/cancers13184503Test


    أضف إلى المفضلة
  7. 7
    Absence of Influence of the Pre-Transplant Immune Status of Recipients on Survivals and Gvhd after Allogeneic Stem Cell Transplantation: A Retrospective Study of 195 Cases

    المؤلفون: Marie C. Béné, Patrice Chevalier, Beatrice Mahe, Nicolas Blin, Marion Eveillard, Alice Garnier, Thierry Guillaume, Viviane Dubruille, M. Audrain, Anne Lok, Amandine Le Bourgeois, Benoit Tessoulin, Pierre Peterlin, Sophie Vantyghem, Philippe Moreau, Baptiste Le Calvez, Thomas Dejoie, Cyrille Touzeau, Steven Le Gouill, Thomas Gastinne

    المصدر: Blood. 136:2-3

    مصطلحات موضوعية: medicine.medical_specialty, Myeloid, Cyclophosphamide, biology, business.industry, Incidence (epidemiology), Immunology, Retrospective cohort study, Cell Biology, Hematology, Biochemistry, Gastroenterology, Transplantation, Regimen, medicine.anatomical_structure, Internal medicine, medicine, biology.protein, Stem cell, Antibody, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7dfd3f6c9d01dd793801baa8530d8c1cTest
    https://doi.org/10.1182/blood-2020-136743Test


    أضف إلى المفضلة
  8. 8
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

    المؤلفون: Philippe Moreau, Pierre Gallas, Pierre Peterlin, Céline Bossard, Cyrille Touzeau, Anne-Sophie Moreau, Thierry Guillaume, A. Lok, Patrice Chevallier, Benoit Tessoulin, N. Blin, J. Moynard, V. Dubruille, F. Perrin, E. Delande, Thomas Gastinne, Patrick Thomaré, Steven Le Gouill, Alice Garnier, Jean-Samuel Boudreault, Béatrice Mahé

    المصدر: Annals of Hematology. 96:943-950

    مصطلحات موضوعية: Adult, medicine.medical_specialty, Neutropenia, Adolescent, Pharmacology, DHAP Regimen, Transplantation, Autologous, Gastroenterology, Dexamethasone, Disease-Free Survival, Carboplatin, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, DHAP, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Aged, Retrospective Studies, business.industry, Lymphoma, Non-Hodgkin, Remission Induction, Cytarabine, Anemia, Hematology, General Medicine, Middle Aged, medicine.disease, Combined Modality Therapy, Hodgkin Disease, Thrombocytopenia, Regimen, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Rituximab, Cisplatin, business, Stem Cell Transplantation, 030215 immunology, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9561f01b3a7f56e589f4099846b3526Test
    https://doi.org/10.1007/s00277-017-2981-2Test


    أضف إلى المفضلة
  9. 9
    A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

    المؤلفون: Soraya Wuilleme, Joëlle Gaschet, Alice Garnier, Benoit Tessoulin, Thierry Guillaume, Yannick Le Bris, Beatrice Mahe, Michel Chérel, Marion Eveillard, Olivier Theisen, Marie-Christine Béné, Cyrille Touzeau, Thomas Gastinne, Juliette Brouazin, Nicolas Blin, Philippe Moreau, Steven Le Gouill, Pierre Peterlin, Camille Debord, Amandine Le Bourgeois, Viviane Dubruille, Patrice Chevallier, Catherine Godon, Anne Lok

    المصدر: Blood. 134:1412-1412

    مصطلحات موضوعية: Univariate analysis, medicine.medical_specialty, Poor prognosis, business.industry, medicine.medical_treatment, Immunology, Significant difference, Cell Biology, Hematology, Biochemistry, Chemotherapy regimen, Gastroenterology, Cytokine, Tyrosine Kinase 3, Internal medicine, Risk stratification, Medicine, Flt3 ligand, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1481c8e290cfafe46e783e8ddb49c3daTest
    https://doi.org/10.1182/blood-2019-125774Test


    أضف إلى المفضلة
  10. 10
    Ptcy + ATG Compared to Ptcy Alone As Gvhd Prophylaxis for Peripheral Blood Stem Cells Allotransplant Is Associated with Significant Lower Incidence of Acute Gvhd without Increasing Relapse or Death By Infection

    المؤلفون: Nicolas Blin, Beatrice Mahe, Thierry Guillaume, Alice Garnier, Viviane Dubruille, Amandine Le Bourgeois, Yannick Le Bris, Marie C. Béné, Thomas Gastinne, Philippe Moreau, Patrice Chevallier, Steven Le Gouill, Benoit Tessoulin, Anne Lok, Pierre Peterlin, Cyrille Touzeau

    المصدر: Blood. 134:4528-4528

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Congenital cytomegalovirus infection, Cell Biology, Hematology, medicine.disease, Biochemistry, Gastroenterology, Fludarabine, Transplantation, Graft-versus-host disease, medicine.anatomical_structure, Internal medicine, Medicine, Clofarabine, Bone marrow, Stem cell, business, Busulfan, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bcea6a3e3583fa2260828b54ce834958Test
    https://doi.org/10.1182/blood-2019-125787Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث